Article info

Original research
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Authors

  • Angela Pizzolla Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Simon Paul Keam Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaTumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Ismael A Vergara Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaMelanoma Institute Australia, Camperdown, New South Wales, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia PubMed articlesGoogle scholar articles
  • Franco Caramia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaTumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Niko Thio Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Minyu Wang Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Nikolce Kocovski Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Daniela Tantalo Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jafar Jabbari Australian Genome Research Facility Ltd, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • George Au-Yeung Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaMedical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Shahneen Sandhu Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaMedical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • David E Gyorki Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Alison Weppler Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Maurizio Perdicchio F Hoffmann-La Roche Ltd, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Grant A McArthur Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Anthony T Papenfuss Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Paul Joseph Neeson Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, AustraliaCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Angela Pizzolla; angela.pizzolla{at}petermac.org; Dr Paul Joseph Neeson; paul.neeson{at}petermac.org
View Full Text

Citation

Pizzolla A, Keam SP, Vergara IA, et al
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment

Publication history

  • Accepted April 5, 2022
  • First published May 12, 2022.
Online issue publication 
May 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.